THE NEXT DIMENSION COMPANY

IntelliPharmaCeutics represents a success story like no other. Since its inception in 1998, the company has become a key global player in the pharmaceutical market. Through flourishing business relations with some of the world’s largest and most demanding clients, IntelliPharmaCeutics continues to exceed expectations.

 

IntelliPharmaCeutics is at the forefront of the design and the development of controlled release drugs. The core drug delivery technology employed by IntelliPharmaCeutics is the patented HYPERMATRIX technology which is a revolutionary drug delivery platform. Utilizing this technology, our scientists are able to provide life cycle management or new chemical entity delivery system solutions for virtually any small molecule. By recognizing that the key to remaining at the forefront of technological know-how requires housing the best and brightest corporate and scientific minds, IntelliPharmaCeutics will continue to make history in its unprecedented growth and delivery in the global pharmaceutical market.  

 

Our company success hinges on the simplicity of our business model: To produce the worlds’ most sophisticated controlled release drug delivery technology surpassing the industry’s most competitive timeframes. Such an aggressive scientific promise   continues to impress many of our competitors and we intend to keep leaping ahead of the curve.

 LATEST NEWS

 

 

 

 

March 27, 2008
Intellipharmaceutics Announces Successful Completion of Pilot Clinical Trials for its Abuse and Alchohol Resistant Sustained Release Oxycodone

August 2, 2007
Par Pharmaceutical Announces Equity Investment in IntelliPharmaCeutics Ltd.


May 1, 2006
IntelliPharmaCeutics and Larasan Pharmaceutical Agree to NDA Program for Controlled Release Analgesic
March 30, 2006
IntelliPharmaCeutics Ltd. Announces Health Canada Compliance for its Canadian Operating Affiliate
January 5, 2006
IntelliPharmaCeutics Announces Agreement
for the Development of a Second Controlled Release Product for Distribution

December 19, 2005

IntelliPharmaCeutics Announces Agreement for the Development of a Controlled Release Product for Distribution in Canada


November 29, 2005
IntelliPharmaCeutics and Par Pharmaceutical
Agree to Controlled Release Generic Drug Development
 

 

 


  Home | Product & Service | Technology | Partnerships | News | Events | Corporate
Overview
| Investor Relations | Careers | Contact us | Press Release
Powered by iNetworks Canada © Copy Rights 2006 IntelliPharmaCeutics Corp. All Rights Reserved.